A

Active Biotech AB publ
STO:ACTI

Watchlist Manager
Active Biotech AB publ
STO:ACTI
Watchlist
Price: 0.292 SEK 0.34% Market Closed
Market Cap: 407.4m SEK
Have any thoughts about
Active Biotech AB publ?
Write Note

Active Biotech AB publ
Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Active Biotech AB publ
Operating Expenses Peer Comparison

Comparables:
BIOG B
BONEX
VITR
SOBI
BIOA B

Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors

Company Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
A
Active Biotech AB publ
STO:ACTI
Operating Expenses
-kr42.3m
CAGR 3-Years
1%
CAGR 5-Years
-1%
CAGR 10-Years
17%
Biogaia AB
STO:BIOG B
Operating Expenses
-kr508.9m
CAGR 3-Years
-17%
CAGR 5-Years
-12%
CAGR 10-Years
N/A
Bonesupport Holding AB
STO:BONEX
Operating Expenses
-kr658.5m
CAGR 3-Years
-35%
CAGR 5-Years
-19%
CAGR 10-Years
N/A
Vitrolife AB
STO:VITR
Operating Expenses
-kr5.6B
CAGR 3-Years
-131%
CAGR 5-Years
-66%
CAGR 10-Years
-39%
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
Operating Expenses
-kr14B
CAGR 3-Years
-23%
CAGR 5-Years
-21%
CAGR 10-Years
-23%
BioArctic AB
STO:BIOA B
Operating Expenses
-kr300.5m
CAGR 3-Years
-34%
CAGR 5-Years
-9%
CAGR 10-Years
N/A

See Also

What is Active Biotech AB publ's Operating Expenses?
Operating Expenses
-42.3m SEK

Based on the financial report for Sep 30, 2024, Active Biotech AB publ's Operating Expenses amounts to -42.3m SEK.

What is Active Biotech AB publ's Operating Expenses growth rate?
Operating Expenses CAGR 10Y
17%

Over the last year, the Operating Expenses growth was 14%. The average annual Operating Expenses growth rates for Active Biotech AB publ have been 1% over the past three years , -1% over the past five years , and 17% over the past ten years .

Back to Top